Asensus Surgical to Participate in the H. C. Wainwright Global Investment Conference

Rhea-AI Summary

Asensus Surgical, Inc. (NYSE American: ASXC) will participate in the H. C. Wainwright Global Investment Conference in Miami, Florida. The fireside chat will occur on Tuesday, May 24, 2022, at 12:00 pm Eastern Time. Interested parties can access the webcast on the company's investor relations page, with a replay available for 90 days. Asensus Surgical focuses on digitizing the surgical experience with its Senhance® Surgical System and Intelligent Surgical Unit™ (ISU™), aiming to improve surgical outcomes through machine vision and augmented intelligence.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the H. C. Wainwright Global Investment Conference in Miami, Florida. The Company’s fireside chat will take place on Tuesday, May 24, 2022 at 12:00 pm Eastern Time.

The H. C. Wainwright Global Investment Conference webcast will be available online on the investor relations page of the Company’s website at https://ir.asensus.com/events-and-presentations. Replay of the webcast will be archived on the website for approximately 90 days.

About Asensus Surgical, Inc.

Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220511005099/en/

INVESTOR CONTACT:

Mark Klausner or Mike Vallie, 443-213-0499

invest@asensus.com

or

MEDIA CONTACT:

Lauren Stredler, 847-271-6891

CG Life

lstredler@cglife.com

Source: Asensus Surgical, Inc.

FAQ

When is Asensus Surgical's participation in the H. C. Wainwright Global Investment Conference?

Asensus Surgical will participate in the H. C. Wainwright Global Investment Conference on Tuesday, May 24, 2022, at 12:00 pm Eastern Time.

Where can I watch Asensus Surgical's conference presentation?

The conference presentation can be watched on Asensus Surgical's investor relations page at https://ir.asensus.com/events-and-presentations.

What is the purpose of Asensus Surgical's participation in the conference?

The purpose is to engage with investors and discuss the company’s advancements in Performance-Guided Surgery and other innovations.

What systems does Asensus Surgical offer?

Asensus Surgical offers the Senhance® Surgical System and Intelligent Surgical Unit™ (ISU™), focusing on enhancing surgical performance.

How does Asensus Surgical improve surgical outcomes?

Asensus Surgical improves surgical outcomes through machine vision, augmented intelligence, and deep learning capabilities.